[
  {
    "ts": "2025-11-04T17:11:00+00:00",
    "headline": "Moderna (MRNA): Assessing Valuation as Cancer Therapy Pipeline Expands with New Multiple Myeloma Trial",
    "summary": "Moderna (MRNA) just began dosing patients in a Phase 1/2 study of mRNA-2808, its experimental T-cell therapy for advanced multiple myeloma. This effort highlights Moderna's growing emphasis on cancer research as it moves beyond COVID-19 vaccines. See our latest analysis for Moderna. Despite excitement over cancer-vaccine partnerships and high-profile buyout speculation, Moderna’s share price return is down 40.7% year-to-date. This reflects a tough run as investors reassess risk after mixed...",
    "url": "https://finance.yahoo.com/news/moderna-mrna-assessing-valuation-cancer-171100897.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "d2390e01-5ceb-3d09-beea-879aa4006bae",
      "content": {
        "id": "d2390e01-5ceb-3d09-beea-879aa4006bae",
        "contentType": "STORY",
        "title": "Moderna (MRNA): Assessing Valuation as Cancer Therapy Pipeline Expands with New Multiple Myeloma Trial",
        "description": "",
        "summary": "Moderna (MRNA) just began dosing patients in a Phase 1/2 study of mRNA-2808, its experimental T-cell therapy for advanced multiple myeloma. This effort highlights Moderna's growing emphasis on cancer research as it moves beyond COVID-19 vaccines. See our latest analysis for Moderna. Despite excitement over cancer-vaccine partnerships and high-profile buyout speculation, Moderna’s share price return is down 40.7% year-to-date. This reflects a tough run as investors reassess risk after mixed...",
        "pubDate": "2025-11-04T17:11:00Z",
        "displayTime": "2025-11-04T17:11:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/759f0ca28b885d5d534769cdaccce534",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lV6Oo0M_C3X63uXoBkpnwQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/759f0ca28b885d5d534769cdaccce534.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KdbFtaQiMRVA6Enl712wNA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/759f0ca28b885d5d534769cdaccce534.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/moderna-mrna-assessing-valuation-cancer-171100897.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/moderna-mrna-assessing-valuation-cancer-171100897.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T13:36:00+00:00",
    "headline": "Should You Buy Moderna Stock Ahead of Q3 Earnings Report?",
    "summary": "MRNA is likely to have faced earnings pressure and pipeline setbacks as waning COVID-19 vaccine demand weighs on its outlook.",
    "url": "https://finance.yahoo.com/news/buy-moderna-stock-ahead-q3-133600619.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "82ac8a18-39f2-35dc-afbd-e7e7492708e2",
      "content": {
        "id": "82ac8a18-39f2-35dc-afbd-e7e7492708e2",
        "contentType": "STORY",
        "title": "Should You Buy Moderna Stock Ahead of Q3 Earnings Report?",
        "description": "",
        "summary": "MRNA is likely to have faced earnings pressure and pipeline setbacks as waning COVID-19 vaccine demand weighs on its outlook.",
        "pubDate": "2025-11-04T13:36:00Z",
        "displayTime": "2025-11-04T13:36:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9e8d93e17a792e7de990e3344e61fa6a",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RbEQ9ffI_C.cs8maxLm5aA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9e8d93e17a792e7de990e3344e61fa6a.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7WrOhRUUvHYeo9ae0mpZAg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9e8d93e17a792e7de990e3344e61fa6a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/buy-moderna-stock-ahead-q3-133600619.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/buy-moderna-stock-ahead-q3-133600619.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "GLAXF"
            },
            {
              "symbol": "GSK"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]